Tribulus (Expanded) for Blood Sugar Regulation

Research suggests that Tribulus terrestris may support blood sugar regulation through several distinct biological mechanisms, including activation of the energy-sensing protein AMPK to reduce liver glucose production, inhibition of the digestive enzymes alpha-glucosidase and alpha-amylase to slow carbohydrate absorption, and aldose reductase inhibition relevant to diabetes-related complications. Studies indicate that saponins and other compounds derived from the plant have demonstrated glucose-lowering effects in diabetic animal models, and a 2023 study specifically identified xanthosine, a naturally occurring compound in the plant, as a potential contributor to these effects via liver signaling pathways. The available body of evidence consists predominantly of in vitro cell studies, animal experiments, and narrative reviews, with the animal research largely relying on chemically induced diabetes models rather than naturally occurring disease, and several reviews include these antidiabetic findings among a broader catalog of the plant's reported pharmacological properties. Notably, the current evidence base lacks robust human clinical trials, which means findings from laboratory and animal settings have not yet been confirmed in controlled studies in people, and this represents a significant limitation in drawing conclusions about real-world effectiveness.